This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) had its target price reduce...
Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) was downgraded by research a...
HC Wainwright downgraded shares of Affimed (NASDAQ:AFMD – Free Report) from a bu...
Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its target price cut by Op...
Needham & Company LLC reaffirmed their buy rating on shares of Absci (NASDAQ:ABS...
Cantor Fitzgerald reiterated their overweight rating on shares of Astria Therape...
Acadia Healthcare (NASDAQ:ACHC – Free Report) had its price target trimmed by Ba...
Needham & Company LLC restated their hold rating on shares of Airbnb (NASDAQ:ABN...
Acadia Healthcare (NASDAQ:ACHC – Free Report) had its price target trimmed by Ke...
Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its price objective decrea...
Alumis (NASDAQ:ALMS – Get Free Report) had its price objective cut by equities r...
Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its price objective cut by...
Royal Bank of Canada reissued their outperform rating on shares of Allogene Ther...
Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) had its price objective upped...
Arvinas (NASDAQ:ARVN – Get Free Report) had its price target lowered by investme...
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its target price reduced...